LMP1 promotes nasal NK/T-cell lymphoma cell function by eIF4E via NF-κB pathway
Authors:
- 23 September 2015
- journal article
- Published by Spandidos Publications in Oncology Reports
- Vol. 34 (6) , 3264-3271
Abstract
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publicationsKeywords
This publication has 27 references indexed in Scilit:
- Differences in Gastric Carcinoma Microenvironment Stratify According to EBV Infection Intensity: Implications for Possible Immune Adjuvant TherapyPLOS Pathogens, 2013
- The tumor suppressive role of miRNA-370 by targeting FoxM1 in acute myeloid leukemiaMolecular Cancer, 2012
- Human papillomavirus and Epstein Barr virus in prostate cancer: Koilocytes indicate potential oncogenic influences of human papillomavirus in prostate cancerThe Prostate, 2012
- Epstein-Barr Virus-Encoded Latent Membrane Protein 1 (LMP1) and LMP2A Function Cooperatively To Promote Carcinoma Development in a Mouse Carcinogenesis ModelJournal of Virology, 2012
- A Human Fab-Based Immunoconjugate Specific for the LMP1 Extracellular Domain Inhibits Nasopharyngeal Carcinoma Growth In Vitro and In VivoMolecular Cancer Therapeutics, 2012
- Extranodal natural killer/T-cell lymphoma: current concepts in biology and treatmentLeukemia & Lymphoma, 2009
- Cap in hand: Targeting eIF4ECell Cycle, 2009
- Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasionCarcinogenesis, 2009
- Current understanding of the role of Epstein–Barr virus in lymphomagenesis and therapeutic approaches to EBV-associated lymphomasLeukemia & Lymphoma, 2008
- LMP1 signaling and activation of NF-κB in LMP1 transgenic miceOncogene, 2005